Some treatments, like Mounjaro, combine GIP and GLP-1 activity to support greater weight loss and metabolic improvements
These warnings can help you make informed decisions about your treatment and ensure your safety
For patients researching GLP-1 weight loss, medical weight loss, semaglutide, or tirzepatide, the most important question is not simply, Which medication causes the most weight loss? A better question is: Which medically supervised approach is appropriate for my health history, body composition, metabolic risk, side-effect tolerance, and long-term maintenance plan
Semaglutide is an injectable prescription medication that is FDA-approved and proven to help overweight adults lose weight and keep it off (when used in combination with a healthy diet and exercise)
This deficiency leads to an inadequate insulin response and elevated blood glucose levels